Study of a Semaglutide Implant for Weight Management
Part of Hormones & metabolism clinical trials.
This study tests a small implant placed under the skin that slowly releases semaglutide, a medication that helps with weight management. It's for people who are overweight but do not have diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a body mass index (BMI) between 27 and 40.
- Your most recent blood sugar test (HbA1c) must be 6.0% or lower, and your fasting blood sugar must be 6.7 mmol/L or less.
- Your kidneys must be working well (eGFR of 60 or higher).
- You cannot have type 1 or type 2 diabetes.
- You cannot have taken any diabetes medication in the past 3 months.
- You should have no major health problems that would make the study unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether gradually lowering the dose of the weight-loss drug semaglutide can help people who have already lost weight keep it off. You may join if you are already taking weekly semaglutide and have lost at least 10% of your starting weight or are at a healthy weight after losing 5%.
This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This trial tests if semaglutide (a weekly injection) helps people who lost less weight than expected after gastric bypass or sleeve surgery. It's for patients who had a high BMI before surgery and are in a special support program.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.